GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 112 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $42,439,000 | +43.7% | 1,775,671 | -12.2% | 0.00% | 0.0% |
| Q4 2020 | $29,526,000 | +5.5% | 2,022,331 | +2.6% | 0.00% | 0.0% |
| Q3 2020 | $27,980,000 | -4.1% | 1,970,417 | -0.7% | 0.00% | 0.0% |
| Q2 2020 | $29,189,000 | +557.1% | 1,984,263 | +84.0% | 0.00% | – |
| Q1 2020 | $4,442,000 | -15.9% | 1,078,157 | -1.8% | 0.00% | – |
| Q4 2019 | $5,282,000 | -21.1% | 1,098,056 | -0.6% | 0.00% | – |
| Q3 2019 | $6,694,000 | -2.6% | 1,104,573 | +4.3% | 0.00% | -100.0% |
| Q2 2019 | $6,873,000 | -5.2% | 1,059,007 | +3.6% | 0.00% | 0.0% |
| Q1 2019 | $7,247,000 | +50.1% | 1,022,153 | +2.9% | 0.00% | – |
| Q4 2018 | $4,827,000 | -49.8% | 993,124 | -24.0% | 0.00% | -100.0% |
| Q3 2018 | $9,612,000 | +34.9% | 1,307,582 | +17.1% | 0.00% | 0.0% |
| Q2 2018 | $7,125,000 | +41.3% | 1,116,180 | +20.4% | 0.00% | – |
| Q1 2018 | $5,042,000 | +33.6% | 926,981 | +2.3% | 0.00% | – |
| Q4 2017 | $3,774,000 | -59.5% | 906,076 | -6.3% | 0.00% | -100.0% |
| Q3 2017 | $9,314,000 | -11.4% | 967,169 | +8.8% | 0.00% | 0.0% |
| Q2 2017 | $10,515,000 | +0.9% | 888,727 | +9.4% | 0.00% | 0.0% |
| Q1 2017 | $10,417,000 | +15.8% | 812,717 | +10.6% | 0.00% | 0.0% |
| Q4 2016 | $8,994,000 | +19.3% | 734,754 | +15.0% | 0.00% | 0.0% |
| Q3 2016 | $7,542,000 | +34.6% | 639,064 | -0.8% | 0.00% | 0.0% |
| Q2 2016 | $5,604,000 | +66.5% | 644,349 | +0.9% | 0.00% | – |
| Q1 2016 | $3,365,000 | -34.3% | 638,491 | -3.2% | 0.00% | -100.0% |
| Q4 2015 | $5,118,000 | +2.0% | 659,410 | +3.5% | 0.00% | 0.0% |
| Q3 2015 | $5,016,000 | -10.7% | 637,412 | +2.8% | 0.00% | 0.0% |
| Q2 2015 | $5,619,000 | -28.9% | 620,288 | +1.8% | 0.00% | 0.0% |
| Q1 2015 | $7,908,000 | +2.5% | 609,225 | +7.5% | 0.00% | 0.0% |
| Q4 2014 | $7,715,000 | +54.1% | 566,757 | +1.5% | 0.00% | 0.0% |
| Q3 2014 | $5,008,000 | -32.6% | 558,342 | +1.6% | 0.00% | 0.0% |
| Q2 2014 | $7,434,000 | +39.6% | 549,498 | +2.6% | 0.00% | 0.0% |
| Q1 2014 | $5,325,000 | -24.0% | 535,628 | +0.4% | 0.00% | – |
| Q4 2013 | $7,009,000 | +43.3% | 533,705 | +32.6% | 0.00% | -100.0% |
| Q3 2013 | $4,891,000 | +52.4% | 402,593 | +29.7% | 0.00% | – |
| Q2 2013 | $3,209,000 | – | 310,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 685,000 | $8,104,000 | 3.00% |
| CADIAN CAPITAL MANAGEMENT, LP | 3,985,360 | $47,147,000 | 2.30% |
| Ghost Tree Capital, LLC | 825,000 | $9,760,000 | 2.03% |
| NORTHPOINTE CAPITAL LLC | 1,248,508 | $14,770,000 | 1.55% |
| Maven Securities LTD | 80,000 | $947,000 | 0.65% |
| Monashee Investment Management LLC | 125,000 | $1,479,000 | 0.62% |
| Bellevue Group AG | 405,178 | $4,793,000 | 0.57% |
| Schonfeld Strategic Advisors LLC | 411,600 | $4,869,000 | 0.50% |
| HighTower Advisors, LLC | 2,360,984 | $27,930,000 | 0.25% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 50,000 | $592,000 | 0.16% |